TuHURA Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for TuHURA Biosciences, Inc. (HURA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Jun 2020Jun 2019Jun 2018
Current Assets
Cash and Cash Equivalents12.663.6714.255.552.393.725.97
Cash & Short-Term Investments12.663.6714.255.552.393.725.97
Accounts Receivable0.440.330.100.000.010.030.04
Inventory0.210.000.000.000.000.000.00
Other Current Assets0.320.160.490.140.000.000.00
Total Current Assets19.614.1614.745.682.854.037.05
Non-Current Assets
Property, Plant & Equipment (Net)0.320.200.420.620.000.000.00
Other Non-Current Assets0.030.000.030.100.000.000.00
Total Non-Current Assets0.360.200.450.720.090.010.03
Total Assets19.974.3615.206.402.944.047.07
Current Liabilities
Accounts Payable3.151.871.920.412.682.071.64
Short-Term Debt0.160.000.000.640.000.000.00
Accrued Liabilities0.860.160.160.040.000.000.00
Other Current Liabilities2.020.140.190.190.000.000.00
Total Current Liabilities5.333.602.877.152.682.071.64
Non-Current Liabilities
Long-Term Debt0.042.320.020.000.000.000.00
Other Non-Current Liabilities0.000.170.240.240.000.000.00
Total Non-Current Liabilities0.042.320.020.180.000.000.00
Total Liabilities5.375.922.897.152.682.071.64
Stockholders' Equity
Common Stock0.040.010.000.000.000.000.00
Retained Earnings-111.12-88.47-59.16-49.48-69.70-60.58-52.44
Accumulated Other Comprehensive Income0.000.000.000.000.000.020.02
Additional Paid-in Capital125.4086.8971.4548.7265.1550.9543.20
Shares Outstanding42.3242.0342.0342.030.000.000.00
Total Stockholders' Equity14.59-1.5612.30-0.75-4.261.975.44
Total Liabilities & Equity19.974.3615.206.402.944.047.07